Lancet: Covaxin phase 2 data shows vaccine safe, induces immune response ...United Arab Emirates

Gulf News - News
Lancet: Covaxin phase 2 data shows vaccine safe, induces immune response
New Delhi: India's first indigenous vaccine against COVID-19, Covaxin, is safe and generates immune response without any serious side effects, according to the interim results of the phase 2 trials published in The Lancet Infectious Diseases journal. The authors of the study noted that the phase 2 results did not asses the efficacy of the vaccine codenamed BBV152. Developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), Pune, the vaccine has been granted emergency use authorisation in clinical trial mode by the Indian government. Covaxin had initially raised concerns among experts over its emergency approva

Hence then, the article about lancet covaxin phase 2 data shows vaccine safe induces immune response was published today ( ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lancet: Covaxin phase 2 data shows vaccine safe, induces immune response )

Apple Storegoogle play

Last updated :

Also on site :